Gliptagreat D 5mg/100mg Tablet SR
Marketer
Mankind Pharma Ltd
Salt Composition
Dapagliflozin (5mg) + Vildagliptin (100mg)
Overview Gliptagreat D 5mg/100mg Tablet SR
Diabetic patients with type 2 mellitus can benefit from Gliptagreat D 5mg/100mg SR tablets, a dual-action medication that aids in regulating blood glucose. This medication, used alongside a balanced diet and exercise regimen, enhances glycemic control. It promotes efficient insulin use, consequently reducing blood sugar. Gliptagreat D 5mg/100mg SR tablets may be administered with or without food, though consistent daily timing is recommended. Dosage is determined by your physician and should not be altered without their consent; discontinuation could elevate blood glucose, potentially leading to severe complications such as renal impairment or vision loss. This medication is a component of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your doctor. Common adverse effects include low blood sugar (hypoglycemia), vaginal infections, urinary tract infections, vertigo, tremors, and cephalalgia. Hydration is crucial to minimize dehydration. Genital yeast infections are possible; maintaining meticulous hygiene helps prevent this. Prior to commencing treatment, discuss any kidney or liver issues, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals require physician consultation. Limit alcohol consumption to reduce the risk of side effects. Regular blood glucose monitoring is essential while taking this medication.
Primary Ingredients of Gliptagreat D 5mg/100mg Tablet SR
The provided text is "undefined," which cannot be rephrased. There is no text to rewrite.
Uses of Gliptagreat D 5mg/100mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gliptagreat D 5mg/100mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliptagreat D 5mg/100mg Sustained-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Gliptagreat D 5mg/100mg Tablet SR:
- Headache
- Vaginal inflammation
- Balanitis
- Urinary tract infection
- Hypoglycemia (low blood glucose level)
- Dizziness
- Tremors
- Fatigue
- Nausea
- Rash
- Back pain
- Polyuria
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Gliptagreat D 5mg/100mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliptagreat D 5mg/100mg Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Gliptagreat D 5mg/100mg Tablet SR works:
Gliptagreat D 5mg/100mg Extended-Release tablets contain a dual-action antidiabetic formulation. Dapagliflozin works by enhancing glucose elimination through the kidneys, thus lowering blood sugar. Vildagliptin concurrently manages glucose production, primarily by stimulating insulin release and suppressing glucagon's hyperglycemic effect.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Gliptagreat D 5mg/100mg SR tablets is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Gliptagreat D 5mg/100mg sustained-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Gliptagreat D 5mg/100mg extended-release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Gliptagreat D 5mg/100mg Tablet SR on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gliptagreat D 5mg/100mg sustained-release tablets to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Gliptagreat D 5mg/100mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gliptagreat D 5mg/100mg Tablet SR :
Should you forget a Gliptagreat D 5mg/100mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliptagreat D 5mg/100mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |





